The Future of
Human Longevity
& Restoration.
Discover the power of MuseMSCs™ – the body's natural solution for ultimate tissue restoration without genetic modification. A paradigm shift in clinical therapeutics.
Higher Efficiency
Natural Sourcing
Tumorigenic Risk
0%
100%
10-15x
CORE ADVANTAGES
What Makes MuseMSCs™ Unique
MuseMSCs™ represent a fundamental breakthrough in stem cell biology, offering the pluripotency of embryonic cells and induced pluripotent stem cells (iPSCs) without the associated ethical or safety constraints.
Natural Prevalence and Sources of MuseMSCs™
MuseMSCs™ are naturally occurring in all Mesenchymal stem cell (MSC) sources such as adult and perinatal tissues. MuseMSCs™ represent 1-3% of the total MSC population.
Pluripotent Yet Non-Tumorigenic
Capable of differentiating all three germ layers without the risk of tumor formation inherent to iPS or ES cells.
Endogenous & Ethically Sourced
Found naturally in adult and perinatal tissues. MuseMSCs™ are dervied from umbilical cord and placental tissue that is donated through AABB licensed tissue procurement sources with consenting donors.
Immune Privileged
Can be administered intravenously across HLA mismatches without the need for immunosuppressive therapy, acting as a universal donor cell.
Self-Homing Ability
MuseMSCs™ detect the Sphingosine 1-phosphate (S1P) signals emitted by damaged tissue, allowing them to actively migrate and engraft precisely where they are needed most.
Long-Term Integration
Unlike traditional therapies that merely provide temporary paracrine effects, MuseMSCs™ structurally integrate and survive long-term as functional tissue.
Mechanism of Action MuseMSCs™
A simple intravenous administration initiates a profound biological cascade.
1. IV Administration
Simple peripheral vein injection, no invasive surgery required.
2. Detect Signals
Cells hone in on S1P damage signals emitted by injured tissue.
3. Phagocytose
Clearance of apoptotic cells to prepare the microenvironment.
4. Differentiate
Structural integration into the specific required tissue type.
SUPERIOR EFFICACY
Traditional MSCs vs. MuseMSCs™
Traditional MSCs are often too large to pass through lung capillaries, resulting in the "pulmonary first-pass effect." MuseMSCs are significantly smaller, allowing them to bypass this trap and reach target tissues efficiently.
Bypass Lung Capillaries
Small size (~13μm) allows smooth passage through the pulmonary barrier.
10–15× Fewer Cells Needed
Due to high homing efficiency, significantly smaller doses yield superior clinical results.